Drug
Khk4323 S
Khk4323 S: highest development phase Phase 1, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KHK4323 IV/S NCT03846466 | Phase 1 | Atopic Dermatitis |
Latest
No recent events.
Follow Khk4323 S on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.